Researcher

Feng Zhang

Profile

Institution

Massachusetts Institute of Technology

Field

Molecular Biology

Feng Zhang is a molecular biologist at the Broad Institute and MIT who was among the first to adapt CRISPR-Cas9 for genome editing in mammalian cells. He has also developed novel CRISPR systems including Cas13 for RNA editing.

Industry Ties

Industry Ties

Editas MedicineBeam TherapeuticsArbor BiotechnologiesSherlock Biosciences

Verified employment, education, publications and profile data sourced from ORCID. Locked — unlock to view.

Fields

• Molecular Biology

Universities

• Massachusetts Institute of Technology